These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28750809)

  • 1. Assessing Allosteric Modulation of CB
    Scott CE; Kendall DA
    Methods Enzymol; 2017; 593():317-342. PubMed ID: 28750809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidinyl Biphenylureas Act as Allosteric Modulators to Activate Cannabinoid Receptor 1 and Initiate
    Jagla CAD; Scott CE; Tang Y; Qiao C; Mateo-Semidey GE; Yudowski GA; Lu D; Kendall DA
    Mol Pharmacol; 2019 Jan; 95(1):1-10. PubMed ID: 30322873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
    Ahn KH; Mahmoud MM; Kendall DA
    J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1).
    Ahn KH; Mahmoud MM; Shim JY; Kendall DA
    J Biol Chem; 2013 Apr; 288(14):9790-9800. PubMed ID: 23449980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational potential of allosteric modulators targeting the cannabinoid CB
    Lu D; Immadi SS; Wu Z; Kendall DA
    Acta Pharmacol Sin; 2019 Mar; 40(3):324-335. PubMed ID: 30333554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
    Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
    Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
    Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB1 Cannabinoid Receptor Signaling and Biased Signaling.
    Leo LM; Abood ME
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive allosteric modulation of the cannabinoid CB
    Green HM; Manning JJ; Greig IR; Ross RA; Finlay DB; Glass M
    Br J Pharmacol; 2024 Oct; 181(19):3642-3662. PubMed ID: 38831545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulators restore orthosteric agonist binding to mutated CB
    Dopart R; Kendall DA
    J Pharm Pharmacol; 2020 Jan; 72(1):84-91. PubMed ID: 31722122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantiomer-specific positive allosteric modulation of CB
    Mitjavila J; Yin D; Kulkarni PM; Zanato C; Thakur GA; Ross R; Greig I; Mackie K; Straiker A
    Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.
    Baillie GL; Horswill JG; Anavi-Goffer S; Reggio PH; Bolognini D; Abood ME; McAllister S; Strange PG; Stephens GJ; Pertwee RG; Ross RA
    Mol Pharmacol; 2013 Feb; 83(2):322-38. PubMed ID: 23160940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
    Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
    Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1.
    Shen S; Wu C; Lin G; Yang X; Zhou Y; Zhao C; Miao Z; Tian X; Wang K; Yang Z; Liu Z; Guo N; Li Y; Xia A; Zhou P; Liu J; Yan W; Ke B; Yang S; Shao Z
    Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2321532121. PubMed ID: 38830102
    [No Abstract]   [Full Text] [Related]  

  • 15. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.
    Dopart R; Lu D; Lichtman AH; Kendall DA
    Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.
    Nguyen T; Li JX; Thomas BF; Wiley JL; Kenakin TP; Zhang Y
    Med Res Rev; 2017 May; 37(3):441-474. PubMed ID: 27879006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor.
    Laprairie RB; Kulkarni PM; Deschamps JR; Kelly MEM; Janero DR; Cascio MG; Stevenson LA; Pertwee RG; Kenakin TP; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2017 Jun; 8(6):1188-1203. PubMed ID: 28103441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CB
    Yang L; Zhu X; Finlay DB; Green H; Glass M; Duffull SB
    Br J Pharmacol; 2023 Oct; 180(20):2661-2676. PubMed ID: 37277184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB
    Trexler KR; Eckard ML; Kinsey SG
    Pharmacol Biochem Behav; 2019 Feb; 177():27-33. PubMed ID: 30597181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study.
    Chung H; Fierro A; Pessoa-Mahana CD
    PLoS One; 2019; 14(7):e0220025. PubMed ID: 31335889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.